Hosted on MSN2mon
ZBH Stock Might Rise Following FDA Nod for Knee Implant ComponentZimmer Biomet Holdings, Inc. ZBH recently received ... Oxford Cementless Partial Knee has become the only FDA-approved cementless partial knee implant in the United States. The latest FDA PMA ...
Hosted on MSN22d
BTIG maintains Zimmer Biomet stock with $126 targetIn product news, Zimmer Biomet received FDA approval for its Oxford Cementless Partial Knee system, making it the only FDA-approved cementless partial knee implant in the U.S. The company plans a ...
Zimmer Biomet Holdings ... a total knee implant component, and FDA’s premarket application supplement approval for the Oxford Cementless Partial Knee. These developments might have had a ...
Zimmer Biomet’s Cian Kelly spoke to ... Kelly spoke about the rewarding work they do around creating knee and hip implants at the Galway site. “Everybody knows someone who has a knee implant ...
Fourth quarter net sales of $2.023 billion increased 4.3% and 4.9% on a constant currency1 basis Fourth quarter diluted earnings per share were $1.20; adjusted1 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results